Yazan J Meqbil

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

The Journal of pharmacology and experimental therapeutics

RSC medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype . The Journal of pharmacology and experimental therapeutics (2024)
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype. The Journal of pharmacology and experimental therapeutics 389 (3) (2024)
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype. The Journal of pharmacology and experimental therapeutics 389 (3) (2024)
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype. The Journal of pharmacology and experimental therapeutics 389 (3) (2024)
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype. The Journal of pharmacology and experimental therapeutics 389 (3) (2024)
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype. The Journal of pharmacology and experimental therapeutics 389 (3) (2024)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Yazan J Meqbil, Richard M Van Rijn
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Yazan J Meqbil, Hongyu Su, Robert J Cassell, Kendall L Mores, Anna M Gutridge, Benjamin R Cummins, Lan Chen, Richard M Van Rijn
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland) 26 (23) (2021)
Krishna K Sharma, Robert J Cassell, Yazan J Meqbil, Hongyu Su, Arryn T Blaine, Benjamin R Cummins, Kendall L Mores, David K Johnson, Richard M Van Rijn, Ryan A Altman
Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. RSC medicinal chemistry 12 (11) (2021)